According to FutureWise analysis the market for anti-obesity drugs in 2023 is US$ 1.78 billion, and is expected to reach US$ 4.08 billion by 2031 at a CAGR of 10.90%.
Anti-obesity drugs, also known as weight loss or anti-obesity medications, are pharmaceutical agents designed to help individuals manage their weight by suppressing appetite, reducing absorption of nutrients, or increasing metabolism. Obesity stimulates the incidence of conditions such as type 2 diabetes and cardiovascular diseases. It also increases the risk of death due to cancer of the oesophagus, colon and liver, rectum, gallbladder, pancreas, and kidney. These drugs are generally prescribed for individuals with a BMI (mass index) of 30 or higher, which is considered obese, or a BMI of 27 or higher with obesity-related conditions like dyslipidemia, high blood pressure, or diabetes.
Anti-obesity drugs can be classified based on their mechanisms of action, including peripherally acting drugs and centrally acting drugs. Centrally-acting drugs are medications that lower heart rate and relieve blood pressure. They function by blocking the signals from the brain to the nervous system, increasing the heart rate and narrowing the blood vessels. Consequently, the heart exerts less force in its pumping action. This promotes smoother blood flow through the body's veins and arteries and also lowers blood pressure. Central-acting drugs may also use to prevent, treat, or improve symptoms of other health conditions, such as attention-deficit/hyperactivity disorder (ADHD), drug withdrawal, such as from opioid pain medicines, or hot flashes in menopause. Further, peripherally acting drugs influence processes outside the central nervous system. These drugs primarily target digestive processes or metabolic functions.
FutureWise Market Research has published a report that provides an insightful analysis anti-obesity drugs market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, anti-obesity drugs market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.